WO2025003769 - AROMATIC HETEROCYCLIC PYRROLIDONE DERIVATIVE AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2025/003769
Publication Date
02.01.2025
International Application No.
PCT/IB2024/000435
International Filing Date
01.07.2024
Title **
[English]
AROMATIC HETEROCYCLIC PYRROLIDONE DERIVATIVE AND USE THEREOF
[French]
DÉRIVÉ DE PYRROLIDONE HÉTÉROCYCLIQUE AROMATIQUE ET SON UTILISATION
[Chinese]
芳杂环并吡咯烷酮类衍生物及其用途
Applicants **
HANGZHOU BIO-CREATIVITY PHARMA-TECH CO., LTD.
Inventors
ZHANG, Fengmin
GU, Dongyan
QIU, Mengyuan
Priority Data
202310795621.2
30.06.2023
CN
202410137084.7
01.02.2024
CN
202410755926.5
12.06.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2062 | |
| EPO | Filing, Examination, Granting | 12912 | |
| Japan | Filing, Examination, Granting | 1736 | |
| South Korea | Filing, Examination, Granting | 1265 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
22,715
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
signaling pathway.[French]
.[Chinese]
信号通路表达异常相关的疾病上的潜力可观。